Back to All Events

Flip the Switch: Activate Your Pre-Licensed EPCIS Capability for DSCSA Compliance Now!

Pharmaceutical manufacturers have until November 27, 2023 to implement capabilities for 100% electronic, interoperable exchange of compliance data in the GS1 Electronic Product Code Information Services (EPCIS) format. Cardinal Health—one of the Big 3 wholesalers—expects their suppliers to be onboarded for EPCIS several months before the November deadline. The company even made reference to potential fines or “discretionary fees” that could be levied for latecomers to the onboarding process.

Attend this exclusive webinar for TraceLink customers on Weds., April 5, 2023 at 11 a.m. EDT (UTC-4) to get a five-step guide on how to activate your pre-licensed EPCIS capability for DSCSA 2023 compliance. Register to attend this live webinar now and you will learn:

  • How to transition to the EPCIS file exchange format from the current ASNs you’re now sending.

  • How to quickly and easily work with the TraceLink Services and Network Success Team to execute an optimized and battle-tested activation process that minimizes disruptions and ensures a smooth go-live.

  • How the TraceLink Product Track Solution reduces the time, cost, and risk associated with DSCSA 2023 compliance.

Previous
Previous
March 28

Pharma USA 2023

Next
Next
April 17

HIMSS Global Health Conference & Exhibition